not tagged
not tagged
['brca']
next up, melinda l. telli, md, md's "integrating immunotherapy and parp inhibitors in patients with germline brca or palb2 mutations" presentation #asco22 
https://t.co/UwVNWBw7PM is a A 501(c)3 nonprofit providing education, community, & resources to those diagnosed with #breastcancer.